Among all enrolled 706 patients, IDO1 expression was positive in 451 (90 %) of 502 patients with evaluable tumor specimens, and the IDO1 expression positivity was determined as higher than 1 % of tumor or immune cells expressed IDO1. The gene discussed is IDO1; the disease is neoplasm.